• OPEN AN ACCOUNT
Indian Indices
Sensex
78,381.85 -257.18
( -0.33%)
Global Indices
Nasdaq
53,210.99 704.96
(1.34%)
Dow Jones
7,621.51 110.79
(1.48%)
Hang Seng
63,983.92 229.02
(0.36%)
Nikkei 225
10,850.37 -17.68
(-0.16%)
Forex
USD-INR
95.40 -0.19
(-0.20%)
EUR-INR
110.00 0.21
(0.19%)
GBP-INR
128.60 0.50
(0.39%)
JPY-INR
0.61 0.01
(2.47%)

EQUITY - MARKET SCREENER

BSE Bharat 22 Index
Industry :  Stock Exchanges
BSE Code
ISIN Demat
Book Value()
1016
N.A
0
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
12.96
4883648.99
EPS(TTM)
Face Value()
Div & Yield %
0
100
2.2
 

Mankind Pharma consolidated net profit rises 31.75% in the March 2026 quarter
May 20,2026
Net profit of Mankind Pharma rose 31.75% to Rs 554.35 crore in the quarter ended March 2026 as against Rs 420.77 crore during the previous quarter ended March 2025. Sales rose 11.81% to Rs 3442.93 crore in the quarter ended March 2026 as against Rs 3079.37 crore during the previous quarter ended March 2025.

For the full year,net profit declined 3.92% to Rs 1912.93 crore in the year ended March 2026 as against Rs 1990.96 crore during the previous year ended March 2025. Sales rose 16.96% to Rs 14277.64 crore in the year ended March 2026 as against Rs 12207.44 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales3442.933079.37 12 14277.6412207.44 17
OPM %27.0122.19 -25.3424.72 -
PBDT905.41746.30 21 3348.613137.55 7
PBT682.33515.43 32 2462.432516.33 -2
NP554.35420.77 32 1912.931990.96 -4